The effect of LfcinB9 on human ovarian cancer cell SK-OV-3 is mediated by inducing apoptosis

Authors:

Abstract
LfcinB9 is a peptide derived from lactoferricin B. In the present study, the effect and relative mechanism of LfcinB9 on human ovarian cancer cell line (SK‐OV‐3) in vitro and in vivo was investigated. The data obtained indicated that LfcinB9 exhibited low hemolysis activity and significantly inhibited the proliferation of SK‐OV‐3 cells in vitro. In addition, the apoptosis of SK‐OV‐3 cells was induced through up‐regulating the production of reactive oxygen species and activating caspase‐3, caspase‐9 on both transcription and translation level. Finally, LfcinB9 significantly prevented the tumor growth in the SK‐OV‐3‐bearing mice model. These results indicated that LfcinB9 could be a potential agent for the treatment of ovarian cancer. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.

This publication has 27 references indexed in Scilit: